[Molecular genetic analysis for malignant gliomas: clinical implications and future directions].
Mizoguchi
Masahiro
M
Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Shono
Tadahisa
T
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D015254:DNA Modification Methylases / Q000235:genetics; D045643:DNA Repair Enzymes / Q000235:genetics; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016147:Genes, Tumor Suppressor; D005910:Glioma / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D006801:Humans; D019656:Loss of Heterozygosity; D035683:MicroRNAs / Q000235:genetics; D025202:Molecular Diagnostic Techniques; D014411:Neoplastic Stem Cells; D015398:Signal Transduction / Q000235:genetics; D000077204:Temozolomide; D025521:Tumor Suppressor Proteins / Q000235:genetics
D018906:Antineoplastic Agents, Alkylating; D035683:MicroRNAs; D025521:Tumor Suppressor Proteins; D003606:Dacarbazine; D015254:DNA Modification Methylases; C515491:MGMT protein, human; D045643:DNA Repair Enzymes; D000077204:Temozolomide